• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATM对V(D)J重组中间产物的感知。

Sensing of intermediates in V(D)J recombination by ATM.

作者信息

Perkins Eric J, Nair Ayyappan, Cowley Dale O, Van Dyke Terry, Chang Yung, Ramsden Dale A

机构信息

Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Genes Dev. 2002 Jan 15;16(2):159-64. doi: 10.1101/gad.956902.

DOI:10.1101/gad.956902
PMID:11799059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC155324/
Abstract

Ataxia-telangiectasia mutated (ATM) is required for resistance to radiation-induced DNA breaks. Here we use chromatin immunoprecipitation to show that ATM also localizes to breaks associated with V(D)J recombination. ATM recruitment to the recombining locus correlates approximately with recruitment of the break-initiating factor RAG1 and precedes efficient break repair, consistent with localization of ATM to normal recombination intermediates. A product of ATM kinase activity, Ser 18-phosphorylated p53, was detected similarly at these breaks, arguing that ATM phosphorylates target proteins in situ. We suggest routine surveillance of intermediates in V(D)J recombination by ATM helps suppress potentially oncogenic translocations when repair fails.

摘要

共济失调毛细血管扩张症突变基因(ATM)对于抵抗辐射诱导的DNA断裂是必需的。在此我们利用染色质免疫沉淀法表明,ATM也定位于与V(D)J重组相关的断裂处。ATM募集到重组位点与断裂起始因子RAG1的募集大致相关,且先于有效的断裂修复,这与ATM定位于正常重组中间体一致。在这些断裂处同样检测到ATM激酶活性的产物——丝氨酸18磷酸化的p53,这表明ATM在原位磷酸化靶蛋白。我们认为,当修复失败时,ATM对V(D)J重组中间体进行常规监测有助于抑制潜在的致癌性易位。

相似文献

1
Sensing of intermediates in V(D)J recombination by ATM.ATM对V(D)J重组中间产物的感知。
Genes Dev. 2002 Jan 15;16(2):159-64. doi: 10.1101/gad.956902.
2
ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo.ATM 和 p53 在体内 V(D)J 重组过程中对 DNA 断裂的细胞周期控制中是必不可少的。
Oncogene. 2010 Feb 18;29(7):957-65. doi: 10.1038/onc.2009.394. Epub 2009 Nov 16.
3
Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions.共济失调毛细血管扩张症突变蛋白和 DNA 依赖性蛋白激酶具有互补的 V(D)J 重组功能。
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2028-33. doi: 10.1073/pnas.1019293108. Epub 2011 Jan 18.
4
Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.ICF综合征患者淋巴母细胞系中ATM的组成型磷酸化,无下游激酶活性。
DNA Repair (Amst). 2006 Apr 8;5(4):432-43. doi: 10.1016/j.dnarep.2005.12.002. Epub 2006 Jan 19.
5
Both V(D)J recombination and radioresistance require DNA-PK kinase activity, though minimal levels suffice for V(D)J recombination.V(D)J重组和辐射抗性都需要DNA-PK激酶活性,不过V(D)J重组所需的活性水平很低。
Nucleic Acids Res. 2000 Jul 15;28(14):2752-61. doi: 10.1093/nar/28.14.2752.
6
ATM prevents unattended DNA double strand breaks on site and in generations to come.共济失调毛细血管扩张症突变基因(ATM)可防止DNA双链断裂在现场及后续世代中无人照管。
Cancer Biol Ther. 2007 Dec;6(12):1837-9. doi: 10.4161/cbt.6.12.5336. Epub 2007 Nov 21.
7
Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development.XLF 修复蛋白与 53BP1 DNA 损伤反应因子在末端连接和淋巴细胞发育中的重叠功能。
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3903-8. doi: 10.1073/pnas.1120160109. Epub 2012 Feb 21.
8
Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.H2AX、NBS1和p53在ATM依赖性DNA损伤反应和肿瘤抑制中的功能相互作用。
Mol Cell Biol. 2005 Jan;25(2):661-70. doi: 10.1128/MCB.25.2.661-670.2005.
9
p53-Independent apoptosis disrupts early organogenesis in embryos lacking both ataxia-telangiectasia mutated and Prkdc.在同时缺乏共济失调毛细血管扩张症突变基因和蛋白激酶DNA激活催化亚基的胚胎中,p53非依赖性凋亡会破坏早期器官发生。
Mol Cancer Res. 2006 May;4(5):311-8. doi: 10.1158/1541-7786.MCR-05-0258.
10
RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.RAG介导的V(D)J重组对于Atm缺陷小鼠的肿瘤发生并非必不可少。
Mol Cell Biol. 2002 May;22(9):3174-7. doi: 10.1128/MCB.22.9.3174-3177.2002.

引用本文的文献

1
Differential expression of a disease-associated variant reveals distinct phenotypic outcomes.疾病相关变体的差异表达揭示了不同的表型结果。
bioRxiv. 2025 Jul 18:2025.07.15.664809. doi: 10.1101/2025.07.15.664809.
2
The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.胶质瘤中的 DNA 双链断裂修复:分子参与者和治疗策略。
Mol Neurobiol. 2022 Sep;59(9):5326-5365. doi: 10.1007/s12035-022-02915-2. Epub 2022 Jun 13.
3
DNA Damage Response and Repair in Adaptive Immunity.适应性免疫中的DNA损伤反应与修复
Front Cell Dev Biol. 2022 May 17;10:884873. doi: 10.3389/fcell.2022.884873. eCollection 2022.
4
Bone Marrow Transplantation as Therapy for Ataxia-Telangiectasia: A Systematic Review.骨髓移植治疗共济失调毛细血管扩张症:一项系统评价。
Cancers (Basel). 2020 Oct 31;12(11):3207. doi: 10.3390/cancers12113207.
5
Repair of G1 induced DNA double-strand breaks in S-G2/M by alternative NHEJ.通过替代 NHEJ 修复 S-G2/M 期 G1 诱导的 DNA 双链断裂。
Nat Commun. 2020 Oct 16;11(1):5239. doi: 10.1038/s41467-020-19060-w.
6
The histone methyltransferase Setd2 is indispensable for V(D)J recombination.组蛋白甲基转移酶 Setd2 对于 V(D)J 重组是不可或缺的。
Nat Commun. 2019 Jul 26;10(1):3353. doi: 10.1038/s41467-019-11282-x.
7
Genetic ataxia telangiectasia porcine model phenocopies the multisystemic features of the human disease.遗传性共济失调毛细血管扩张症猪模型模拟了人类疾病的多系统特征。
Biochim Biophys Acta Mol Basis Dis. 2017 Nov;1863(11):2862-2870. doi: 10.1016/j.bbadis.2017.07.020. Epub 2017 Jul 23.
8
V(D)J Recombination Exploits DNA Damage Responses to Promote Immunity.V(D)J重组利用DNA损伤反应来促进免疫。
Trends Genet. 2017 Jul;33(7):479-489. doi: 10.1016/j.tig.2017.04.006. Epub 2017 May 19.
9
Immature Lymphocytes Inhibit and Transcription and V(D)J Recombination in Response to DNA Double-Strand Breaks.未成熟淋巴细胞对DNA双链断裂作出反应,抑制转录和V(D)J重组。
J Immunol. 2017 Apr 1;198(7):2943-2956. doi: 10.4049/jimmunol.1601639. Epub 2017 Feb 17.
10
Programmed DNA breaks in lymphoid cells: repair mechanisms and consequences in human disease.淋巴细胞中的程序性DNA断裂:人类疾病中的修复机制及后果
Immunology. 2016 Jan;147(1):11-20. doi: 10.1111/imm.12547. Epub 2015 Nov 18.

本文引用的文献

1
DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?作为DNA损伤传感器的DNA-PK、ATM和ATR:同一主题的变体?
Curr Opin Cell Biol. 2001 Apr;13(2):225-31. doi: 10.1016/s0955-0674(00)00201-5.
2
Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX.NBS1和γ-H2AX对RAG介导的VDJ切割的反应。
Science. 2000 Dec 8;290(5498):1962-5. doi: 10.1126/science.290.5498.1962.
3
Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage.小鼠p53蛋白第18位丝氨酸的磷酸化调节p53对DNA损伤的反应。
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11936-41. doi: 10.1073/pnas.220252297.
4
Signal joint formation is also impaired in DNA-dependent protein kinase catalytic subunit knockout cells.在DNA依赖性蛋白激酶催化亚基敲除细胞中,信号接头的形成也受到损害。
J Immunol. 2000 Oct 1;165(7):3883-9. doi: 10.4049/jimmunol.165.7.3883.
5
Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice.来自Atm基因缺陷小鼠的淋巴瘤中α/δ T细胞受体基因座内的异常重排。
Blood. 2000 Sep 1;96(5):1940-6.
6
DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.小鼠中的DNA连接酶IV缺陷通过p53途径导致神经发生缺陷和胚胎致死。
Mol Cell. 2000 Jun;5(6):993-1002. doi: 10.1016/s1097-2765(00)80264-6.
7
Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.重组激活基因(RAG)2介导的V(D)J重组对于Atm缺陷小鼠的肿瘤发生并非必不可少。
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6664-9. doi: 10.1073/pnas.97.12.6664.
8
DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.DNA修复蛋白Ku80可抑制染色体畸变和恶性转化。
Nature. 2000 Mar 30;404(6777):510-4. doi: 10.1038/35006670.
9
Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation.通过甲醛交联染色质免疫沉淀法在体内绘制染色体蛋白图谱。
Trends Biochem Sci. 2000 Mar;25(3):99-104. doi: 10.1016/s0968-0004(99)01535-2.
10
ATM: a mediator of multiple responses to genotoxic stress.ATM:基因毒性应激多种反应的介导因子。
Oncogene. 1999 Nov 1;18(45):6135-44. doi: 10.1038/sj.onc.1203124.